WHO recognises 'concerning news' of COVID-19 vaccines not working against variants
3 years, 11 months ago

WHO recognises 'concerning news' of COVID-19 vaccines not working against variants

Firstpost  

Booster shots will likely be needed, since new virus variants are spreading globally and likely to become the predominant strains. The head of the World Health Organization said Monday the emergence of new COVID-19 variants has raised questions about whether or not existing vaccines will work, calling it “concerning news” that the vaccines developed so far may be less effective against the variant first detected in South Africa. Tedros Adhanom Ghebreyesus said at a media briefing that South Africa’s decision on Sunday to suspend its vaccination campaign using the AstraZeneca vaccine is “a reminder that we need to do everything we can to reduce circulation of the virus with proven public health measures.” He said it was increasingly clear that vaccine manufacturers would need to tweak their existing shots to address the ongoing genetic evolution of the coronavirus, saying booster shots would most likely be necessary, especially since new variants of the virus are now spreading globally and appear likely to become the predominant strains. That designation would allow millions of doses to be shipped to poor countries as part of a UN-backed effort to distribute COVID-19 vaccines worldwide known as COVAX. Other COVID-19 vaccines developed by Novavax, Pfizer and BioNTech and Johnson & Johnson also appear to be less effective against the strain first identified in South Africa, although they may prevent severe disease.

South Africa Vaccines Vaccine Recognises Concerning  south  countries  variants  covid19  vaccine  virus  shots  likely  vaccines  working  recognises  concerning  developed

History of this topic

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. In a statement, Gilead said it has “an ongoing …

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Live Mint  

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. In a statement, Gilead said it has “an ongoing commitment to helping enable access to HIV prevention and treatment options where the need is the greatest.” Among the 120 countries eligible for generic version are 18 mostly African countries that …

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?
Trending News
1 month, 1 week ago

A twice-yearly shot could help end AIDS. But will it get to everyone who needs it?

Associated Press  

MEXICO CITY — It’s been called the closest the world has ever come to a vaccine against the AIDS virus. In a statement, Gilead said it has “an ongoing commitment to helping enable access to HIV prevention and treatment options where the need is the greatest.” Among the 120 countries eligible for generic version are 18 mostly African countries that …

Why Americans are opting out of getting a COVID booster shot
1 month, 2 weeks ago

Why Americans are opting out of getting a COVID booster shot

Daily Mail  

A recent survey reveals that a significant number of Americans are unlikely to get a COVID-19 booster vaccine this season. Conducted by the Pew Research Center between October 21 and 27, the survey of 9,593 U.S. adults found that 60% of respondents said they would 'probably not' get an updated vaccine. A full 81% of Republicans said they probably wouldn't …

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin
1 month, 3 weeks ago

PopVax Announces that the U.S. National Institute of Allergy and Infectious Diseases will Conduct and Sponsor the U.S.-based Phase I Clinical Trial of PopVax’s Next-Generation mRNA-LNP COVID-19 Vaccin

Live Mint  

MUMBAI, India & HYDERABAD, India – Business Wire India PopVax, an Indian full-stack biotechnology company developing novel mRNA vaccines and therapeutics using machine learning-enabled computational protein design, is pleased to announce that it has been selected for inclusion in the U.S. Government’s Project NextGen. As part of this initiative, the National Institute of Allergy and Infectious Diseases, part of the …

What to know about the available Covid-19, flu and RSV vaccines
3 months, 3 weeks ago

What to know about the available Covid-19, flu and RSV vaccines

CNN  

CNN — It’s that time of year when any cough or sniffle could be Covid-19, flu or RSV — but there are ways to fend them off. Last year was the first year that the US had vaccines available to protect against all three major respiratory viruses — Covid-19, flu and RSV — but vaccine uptake was low for the …

For people without insurance, updated Covid-19 shots are no longer free of charge at pharmacies
4 months ago

For people without insurance, updated Covid-19 shots are no longer free of charge at pharmacies

CNN  

CNN — The rollout of updated Covid-19 vaccines has begun in the United States, but for the first time, the shots will no longer be free of charge for people without insurance at their local pharmacy. Last year, as the shots transitioned to the commercial market, the US Centers for Disease Control and Prevention’s Bridge Access Program provided free Covid-19 …

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration
4 months ago

New COVID-19 vaccines targeting JN.1 variant under review by Therapeutic Goods Administration

ABC  

Australia's national drug regulator is evaluating the safety and efficacy of two new COVID-19 vaccines designed to provide better protection against new variants of the virus. While there is no longer much circulation of the original JN.1 variant in Australia, Professor Esterman said the new vaccines — targeting JN.1 — would likely still prove highly effective. While TGA approval isn't …

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine
4 months, 1 week ago

Recent breakthrough in COVID-19 vaccination: Indian Immunologicals Ltd unveils first needle-free booster vaccine

Hindustan Times  

In a recent development, Hyderabad-based Indian Immunologicals Ltd in collaboration with Griffith University in Australia has made a significant breakthrough in COVID-19 vaccination technology. Indian Immunologicals Ltd unveils first needle-free booster vaccine “This accomplishment signifies a major step forward in our battle against COVID-19. According to the press release, the innovative vaccine sports an attenuated formulation that uses advanced codon …

The new COVID vaccine is out — but you might not want to rush to get it
4 months, 1 week ago

The new COVID vaccine is out — but you might not want to rush to get it

Raw Story  

The FDA has approved an updated covid shot for everyone 6 months old and up, which renews a now-annual quandary for Americans: Get the shot now, with the latest covid outbreak sweeping the country, or hold it in reserve for the winter wave? “Covid is still very transmissible, very new, and people congregate inside in air-conditioned rooms during the summer,” …

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?
4 months, 2 weeks ago

As COVID wave wallops California, new vaccines arrive this week. Will it be a turning point?

LA Times  

New COVID-19 vaccines are expected to be available as soon as this week, a promising development amid California’s potent and enduring summer wave of the disease. “I have a tremendous empathy, having seen people struggle with long COVID in their 30s and 40s, people who you might think were otherwise low-risk,” Dr. Peter Marks, the FDA’s vaccine chief, said Friday. …

What To Know About The New COVID-19 Shots For 2024-2025
4 months, 2 weeks ago

What To Know About The New COVID-19 Shots For 2024-2025

Huff Post  

Jasmin Merdan via Getty Images You can expect to start seeing new COVID vaccines in your pharmacy and doctor's office in the coming days. The new vaccines are an update from last year’s shots and aim to keep people better protected by targeting a recently dominant COVID-19 subvariant, KP.2, which more closely resembles the subvariants that are currently making people …

FDA approves updated COVID-19 vaccines; shots should be available in days
4 months, 2 weeks ago

FDA approves updated COVID-19 vaccines; shots should be available in days

LA Times  

With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses of the new COVID019 vaccine. U.S. regulators approved updated COVID-19 vaccines on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter too. “We strongly encourage those who are eligible to consider receiving …

The new COVID shot is now available. Here's what you need to know
4 months, 2 weeks ago

The new COVID shot is now available. Here's what you need to know

NPR  

The new COVID shot is now available. "But if we can prevent people from getting serious cases that end up in emergency rooms, hospitals or worse — dead — that’s what we’re trying to do with these vaccines.” Sponsor Message On average across all age groups, the two mRNA vaccines should cut the risk of having COVID-19 by 60% to …

COVID-19 variant KP.3.1.1 predominant in US as infections continue ticking up
4 months, 2 weeks ago

COVID-19 variant KP.3.1.1 predominant in US as infections continue ticking up

China Daily  

LOS ANGELES - The KP.3.1.1 COVID-19 variant, now the predominant SARS-CoV-2 variant circulating in the United States, has been causing increasing infections in the country, the latest data from the US Centers for Disease Control and Prevention showed. For the two-week period ending Aug 17, KP.3.1.1 is predicted to account for between 31 percent and 43 percent of COVID-19 clinical …

Olympics Sees 40-Plus COVID Cases as Global Infections Rise: WHO
5 months ago

Olympics Sees 40-Plus COVID Cases as Global Infections Rise: WHO

Deccan Chronicle  

Geneva: More than 40 athletes at the Paris Olympics have tested positive for Covid-19, highlighting a new global rise in cases as vaccination coverage plunges, the World Health Organization said Tuesday. Data from 84 countries shows that the percentage of positive tests for SARS-CoV-2 -- the virus that causes Covid-19 disease -- "has been rising for several weeks", she told …

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive
5 months, 3 weeks ago

‘Still not over’: WHO cautions of COVID-19 threat ahead of summer holidays after US President Joe Biden tests positive

Live Mint  

New Delhi: With US President Joe Biden testing positive for COVID-19 before the Presidential elections, the World Health Organisation has warned the public that Covid is still not over. WHO director-general Tedros Adhanom Ghebreyesus issued a warning, stating that vaccination rates among health professionals and the over-60s—two demographics most at risk of dying from COVID—are alarmingly falling. Globally, 9.8 million …

‘Playing COVID roulette’: Some infected by FLiRT variants report their most unpleasant symptoms yet
6 months ago

‘Playing COVID roulette’: Some infected by FLiRT variants report their most unpleasant symptoms yet

LA Times  

A large number of travelers make their way through Tom Bradley International Terminal at LAX during the busy July 4 holiday. Each time you get COVID, he said, is “kind of like playing COVID roulette.” This underscores the need for caution during summer travel and activities, even though the overall risk remains relatively mild. and I can’t stand up for …

Here are the numbers: COVID-19 is ticking up in some places, but levels remain low
6 months, 1 week ago

Here are the numbers: COVID-19 is ticking up in some places, but levels remain low

Associated Press  

Here’s a look at the state of COVID-19 in the U.S. as the Centers for Disease Control and Prevention establishes its latest advice on vaccinations. Nearly 26,000 people died from COVID-19 in the U.S. in the week ending Jan. 9, 2021 — the highest weekly toll in the pandemic. Cases Individual COVID-19 cases are no longer tracked, but health officials …

As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign
6 months, 1 week ago

As COVID-19 ticks up in some places, US health officials recommend a fall vaccination campaign

Associated Press  

NEW YORK — With fresh COVID-19 cases bubbling up in some parts of the country, health officials are setting course for a fall vaccination campaign. What’s more, health officials have reported upticks this month in COVID-19-associated emergency room visits and hospitalizations, and a pronounced increase in positive test results in the southwestern U.S. It’s not clear whether that’s a sign …

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign
6 months, 1 week ago

As COVID-19 ticks up in some places, US advisers recommend a fall vaccination campaign

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Please enter a valid email address Please enter a valid email address SIGN UP I would like to be emailed about offers, events and updates from The Independent. Please try again later {{ …

African and European leaders push for vaccines for Africa after COVID-19 exposed inequalities
6 months, 2 weeks ago

African and European leaders push for vaccines for Africa after COVID-19 exposed inequalities

LA Times  

European and African leaders gather at the African Vaccine Manufacturing Accelerator conference in Paris on June 20, 2024. French President Emmanuel Macron joined several African leaders Thursday to kick off a planned $1-billion project to accelerate the rollout of vaccines in Africa, after the COVID-19 pandemic exposed gaping inequalities in access to them. Many African leaders and advocacy groups say …

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines
7 months ago

FDA advisers urge targeting JN.1 strain in recipe for fall’s COVID vaccines

Associated Press  

WASHINGTON — Government advisers Wednesday said it’s time to update the recipe for the COVID-19 vaccines Americans will receive in the fall -- targeting a version of the ever-evolving coronavirus called JN.1. But just a few months later, numerous offshoots of JN.1 already are on the rise, prompting Moderna and Pfizer to also test a slightly different vaccine formula targeting …

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines
7 months, 4 weeks ago

Covishield Side Effects: Doctors' Group Urges Govt to Review All Covid Vaccines

News 18  

In the wake of pharmaceutical giant AstraZeneca admitting in a UK court that its Covid vaccine can cause blood clots in rare cases, a group of doctors on Thursday expressed deep concern over the safety of the Covishield vaccine manufactured by the Serum Institute of India. At a press conference, the doctors, under the banner of the Awaken India Movement, …

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021
8 months ago

After AstraZeneca covid-19 vax recall worldwide, Serum says it stopped manufacturing jabs in Dec 2021

Live Mint  

New Delhi: The Serum Institute of India on Wednesday said it has stopped making and supplying covid-19 vaccine Covishield after AstraZeneca, the British drugmaker that helped develop the vaccine, announced it too was withdrawing its version of the jab worldwide. The development follows the launch of a class action suit in the UK over allegations that the UK vaccine caused …

AstraZeneca pulls its COVID-19 vaccine from the European market
8 months ago

AstraZeneca pulls its COVID-19 vaccine from the European market

Associated Press  

LONDON — The pharma giant AstraZeneca has requested that the European authorization for its COVID-19 vaccine be pulled, according to the EU medicines regulator. In an update on the European Medicines Agency’s website Wednesday, the regulator said that the approval for AstraZeneca’s Vaxzevria had been withdrawn “at the request of the marketing authorization holder.” AstraZeneca’s COVID-19 vaccine was first given …

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand
8 months ago

AstraZeneca withdraws COVID-19 vaccine citing a decline in demand

ABC  

In short: Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. Pharmaceutical company AstraZeneca has started a global withdrawal of its COVID-19 vaccine, Vaxzevria, which has not been available in Australia since March 2023. AstraZeneca has initiated the worldwide withdrawal of its COVID-19 vaccine due to …

COVID-19 vaccines: Much ado about known unknowns
8 months ago

COVID-19 vaccines: Much ado about known unknowns

The Hindu  

There are things we know that we don’t know. This risk was identified and flagged back in 2021; packaging was modified to insert information associated with the side effects; even the WHO wrote about it first in May 2021 and then in 2023.Read Bindu Shajan Perapaddan’s report on the rare vaccine side-effect is “no secret” and they are “well aware …

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns
8 months, 1 week ago

AstraZeneca reaffirms Covid vaccine safety amid rare side effect concerns

India TV News  

In response to recent concerns regarding potential rare side effects associated with the AstraZeneca-Oxford COVID-19 vaccine, the pharmaceutical company has underscored its unwavering commitment to patient safety while affirming the vaccine's overall safety profile. This comes in the wake of a recent admission by AstraZeneca, the pharmaceutical company, that its Covid vaccine Covishield and Vaxzevria "can, in very rare cases, …

A German man who received 217 COVID vaccinations becomes focus of new immunisation research
10 months ago

A German man who received 217 COVID vaccinations becomes focus of new immunisation research

ABC  

In short: German researchers have studied the immune response of a 62-year-old man who they say had received more than 200 COVID shots for "private reasons" within the space of 29 months. German researchers have studied the immune response of a 62-year-old man who they say had received more than 200 COVID shots for "private reasons" within the space of …

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring
10 months, 1 week ago

'Defences tend to fade over time': US health agency recommends older to get another COVID shot this spring

India TV News  

Washington: Older US adults should roll up their sleeves for another COVID-19 shot, even if they got a booster in the fall, an influential government advisory panel said on Wednesday. The panel voted 11-1 to say Americans 65 and older should get another dose of the updated vaccine that became available in September — if at least four months have …

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination
10 months, 2 weeks ago

Global study quantifies rise in blood clots, heart inflammation following COVID-19 vaccination

The Hindu  

One of the largest assessments of its kind, spanning 99 million people and investigating reports of adverse reactions following COVID-19 vaccination, found that instances of Guillain Barre Syndrome, myocarditis, pericarditis and cerebral venous sinus thrombosis were at least 1.5 times more than expected following inoculation with mRNA and ChadOX1 vaccines. The Global Covid Vaccine Safety Project, which made the assessment, …

Does frequently updating COVID-19 vaccines have any benefits? | Explained
10 months, 3 weeks ago

Does frequently updating COVID-19 vaccines have any benefits? | Explained

The Hindu  

Researchers update the composition of influenza vaccines every six months to match the strains of the virus that are circulating in the wild, so that the shots may provide protective immunity against the flu. The VE of COVID-19 vaccines varies according to the disease’s progression as well as the circulating strains. Thus, researchers worldwide rushed to revise COVID-19 vaccines that …

Newest COVID shots are 54% effective in preventing symptoms, CDC finds
11 months, 1 week ago

Newest COVID shots are 54% effective in preventing symptoms, CDC finds

Associated Press  

NEW YORK — The latest versions of COVID-19 vaccines were 54% effective at preventing symptomatic infection in adults, according to the first U.S. study to assess how well the shots work. The 54% finding is similar to what’s been reported in other countries, and it’s also about what was reported for an earlier vaccine version, said the Ruth Link-Gelles of …

World leaders to meet to discuss threat of hypothetical ‘Disease X’ in Davos
11 months, 3 weeks ago

World leaders to meet to discuss threat of hypothetical ‘Disease X’ in Davos

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. It’s known by the placeholder name of Disease X, …

Nearly 10,000 COVID deaths reported globally last month, fueled by holiday gatherings and new variant
11 months, 4 weeks ago

Nearly 10,000 COVID deaths reported globally last month, fueled by holiday gatherings and new variant

LA Times  

Tedros Adhanom Ghebreyesus, the director-general of the World Health Organization, speaks at a news conference in Geneva last year. The head of the World Health Organization said Wednesday that holiday gatherings and the spread of the most prominent coronavirus variant globally led to increased transmission of COVID-19 last month. Tedros Adhanom Ghebreyesus said nearly 10,000 deaths were reported in December, …

Nearly 10,000 died from COVID-19 last month, fueled by holiday gatherings and new variant, WHO says
11 months, 4 weeks ago

Nearly 10,000 died from COVID-19 last month, fueled by holiday gatherings and new variant, WHO says

Associated Press  

GENEVA — The head of the U.N. health agency said Wednesday holiday gatherings and the spread of the most prominent variant globally led to increased transmission of COVID-19 last month. Tedros Adhanom Ghebreyesus said nearly 10,000 deaths were reported in December, while hospital admissions during the month jumped 42% in nearly 50 countries — mostly in Europe and the Americas …

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data
1 year ago

Over 220 crore COVID vaccine doses administered across India, but less than 23 crore booster doses: Health Ministry data

The Hindu  

A total of 220.67 crore COVID vaccine doses have been administered across the country as on December 21 this year, according to data released by the Health Ministry on Wednesday. However, only 22.88 crore precautionary or booster doses have been administered across the country among the eligible adult population. Despite the recent increase of people infected with the JN.1 COVID …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

JN.1 Covid variant: Health experts advise elderly to mask up
1 year ago

JN.1 Covid variant: Health experts advise elderly to mask up

Hindustan Times  

With the country witnessing a surge in Covid cases of the JN.1 sub-variant, and an increased risk of other respiratory diseases with the onset of winter, experts at the Post Graduate Institute of Medical Education and Research have advised people, especially the elderly to take precautionary measures. The current treatments for Covid-19 are likely to work against this variant, according …

COVID-19 Update: India records 260 new cases, total active at 1,828
1 year ago

COVID-19 Update: India records 260 new cases, total active at 1,828

Live Mint  

India reported 260 new cases of COVID-19, with active cases rising to 1,828, as per the latest data from the Union Health Ministry on December 18. Centre Urges States to Heighten Vigilance The central government has written to states and union territories, urging them to maintain "continuous vigilance" in light of the recent surge in COVID-19 cases and the identification …

COVID-19 makes a wintertime comeback
1 year ago

COVID-19 makes a wintertime comeback

Hindustan Times  

Germany is sniffling and coughing again. "We no longer see severe cases," he said, adding just one patient, aged 94, had to go to the hospital due to COVID-19. With as much as 10% of the country sick, according to Germany's Robert Koch Institute for public health, offices and services are struggling to stay open. Other forms of PCR testing …

Covid is on the rise as…: WHO alerts ‘virus still changing, evolving’ as JN.1 subvariant cases surge
1 year ago

Covid is on the rise as…: WHO alerts ‘virus still changing, evolving’ as JN.1 subvariant cases surge

Live Mint  

The World Health Organization has called for strong surveillance and sequence sharing as the virus evolves and new COVID sub-variants emerge. In the wake of the surge in respiratory diseases and new JN.1 COVID sub-variant, the World Health Organisation said that the virus is evolving and changing and urged the member states to continue with strong surveillance and sequence sharing. …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

Covid-19 vaccination rate is ‘lower than we’d like to see,’ CDC says
1 year, 1 month ago

Covid-19 vaccination rate is ‘lower than we’d like to see,’ CDC says

CNN  

CNN — Respiratory virus season is ramping up across the United States, and the US Centers for Disease Control and Prevention is warning that low vaccination rates are leaving many at risk. There are a number of reasons why it’s important for people to get the latest Covid-19 vaccine, CDC Director Dr. Mandy Cohen told CNN. “COVID-19 vaccines don’t prevent …

4 out of 5 Mexicans who got a flu shot this year turned down Cuban and Russian COVID-19 vaccines
1 year, 1 month ago

4 out of 5 Mexicans who got a flu shot this year turned down Cuban and Russian COVID-19 vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Four out of five people …

There’s a new COVID-19 variant. What's JN.1, will vaccines work against it?
1 year, 2 months ago

There’s a new COVID-19 variant. What's JN.1, will vaccines work against it?

Firstpost  

Scientists have detected a new COVID-19 variant, called JN.1, believed to be a descendant of the fast-spreading Pirola strain. Late last week, the United States’ Centers for Disease Control and Prevention flagged a new variant, known as JN.1, in its report, with officials saying they were “learning” about it. Amesh Adalja, MD, a senior scholar at the Johns Hopkins Center …

Few kids are getting the latest COVID shots. Is it misinformation or a lack of access?
1 year, 2 months ago

Few kids are getting the latest COVID shots. Is it misinformation or a lack of access?

Salon  

When the COVID-19 pandemic hit, children’s lives were upended. Related The real reason the new RSV shot is hard for some parents to find Today, vaccines are still on the market for children over the age of six months, including a new COVID-19 shot that became available across the country in mid-September and is formulated to target the most prevalent …

New COVID vaccines are here: Now’s the time to get one, officials say
1 year, 2 months ago

New COVID vaccines are here: Now’s the time to get one, officials say

LA Times  

With Halloween just days away, and the wider autumn and winter holiday season fast approaching, now is the time for most everyone to get their updated COVID-19 vaccine, officials say — especially since initial supply shortages have eased. “We have a good supply of COVID-19 and flu vaccines in Los Angeles County and there are options for everyone 6 months …

Discover Related